Ex Parte Qin et alDownload PDFPatent Trial and Appeal BoardOct 31, 201714024812 (P.T.A.B. Oct. 31, 2017) Copy Citation United States Patent and Trademark Office UNITED STATES DEPARTMENT OF COMMERCE United States Patent and Trademark Office Address: COMMISSIONER FOR PATENTS P.O.Box 1450 Alexandria, Virginia 22313-1450 www.uspto.gov APPLICATION NO. FILING DATE FIRST NAMED INVENTOR ATTORNEY DOCKET NO. CONFIRMATION NO. 14/024,812 09/12/2013 Jian Qin 64887803US01 1250 23556 7590 11/01/2017 KIMBERLY-CLARK WORLDWIDE, INC. Patent Docketing 2300 Winchester Rd. NEENAH, WI54956 EXAMINER BOYLE, KARA BRADY ART UNIT PAPER NUMBER 1766 MAIL DATE DELIVERY MODE 11/01/2017 PAPER Please find below and/or attached an Office communication concerning this application or proceeding. The time period for reply, if any, is set in the attached communication. PTOL-90A (Rev. 04/07) UNITED STATES PATENT AND TRADEMARK OFFICE BEFORE THE PATENT TRIAL AND APPEAL BOARD Ex parte JIAN QIN, CHARLES WILSON COLMAN, DEBORAH JOY CALEWARTS, and PALANIRAJ RAMASWAMI WALLAJAPET Appeal 2017-000891 Application 14/024,812 Technology Center 1700 Before LINDA M. GAUDETTE, DONNA M. PRAISS, and MICHAEL G. McMANUS, Administrative Patent Judges. McMANUS, Administrative Patent Judge. DECISION ON APPEAL The Examiner finally rejected claims 1, 2, 5—7, 9-10, and 21 of Application 14/024,812 under 35 U.S.C. §§ 102 and 112. Final Act. (Dec. 8, 2015) 2—3. Appellant1 seeks reversal of these rejections pursuant to 35 U.S.C. § 134(a). We have jurisdiction under 35 U.S.C. § 6. For the reasons set forth below, we AFFIRM. 1 Kimberly-Clark Worldwide, Inc. is identified as the real party in interest, Appeal Br. 1, and is also the Applicant. Appeal 2017-000891 Application 14/024,812 BACKGROUND The present application generally relates to a frothed polymer foam including a highly crystalline polyolefin dispersion, a cross-linkable binder and a surfactant. Spec., Abstract. The foam of the present application may find use in products which absorb aqueous fluids, such as diapers, training pants, youth pants, feminine hygiene products, adult incontinence garments and pads, wiping towels, sponges, wound dressings, surgical sponges, and the like. Spec. 1. Claim 1 is representative of the pending claims and is reproduced below: 1. An open cell foam comprising a composition comprising a highly crystalline polyolefin dispersion; a cross-linkable binder; and a surfactant. Appeal Br. 10 (Claims App.). REJECTIONS On appeal, the Examiner maintains the following rejections: 1. Claims 1, 2, 5—7, 9, 10, and 21 are rejected under 35 U.S.C. § 112(b) as failing to particularly point out and distinctly claim the subject matter which the inventors regard as their invention. Final Act. 2. 2. Claims 1, 2, 5, 7, and 10 are rejected under 35 U.S.C. § 102(a) as anticipated by Strandburg et al. (US 2006/0211781 Al, pub. Sept. 21, 2006) (hereinafter “Strandburg”). Id. at 3. 3. Claims 1, 2, 5—7, 9, 10, and 21 are rejected under 35 U.S.C. § 102(a) as anticipated by Wang (US 5,939,464, iss. Aug. 17, 1999) (hereinafter “Wang”). Id. at 3. 2 Appeal 2017-000891 Application 14/024,812 DISCUSSION Rejection 1. The Examiner rejected all pending claims on the basis of indefmiteness. Final Act. 2. The Examiner determined that the limitation “highly crystalline polyolefin” (found in all claims) is indefinite. Specifically, the Examiner determined that “highly crystalline polyolefin” is not a term of art which one of ordinary skill in the art could readily define nor does the Specification define the degree of crystallinity that a polyolefin must have in order to be “highly crystalline.” Final Act. 2; Answer 6. A patent must “conclude with one or more claims particularly pointing out and distinctly claiming the subject matter which the inventor or a joint inventor regards as the invention.” 35 U.S.C. § 112(b). The Board recently reiterated that a patent claim is accorded its broadest reasonable interpretation in evaluating indefmiteness. In re McAward, Appeal No. 2015-006416, 2017 WL 3669566 (PTAB Aug. 25, 2017) (precedential); see also In re Packard, 751 F.3d 1307, 1310 (Fed. Cir. 2014) (per curiam). “[Djuring patent prosecution when claims can be amended, ambiguities should be recognized, scope and breadth of language explored, and clarification imposed.” In re Zletz, 893 F.2d 319, 321 (Fed. Cir. 1989). “If a claim is amenable to two or more plausible claim constructions, the USPTO is justified in requiring the applicant to more precisely define the metes and bounds of the claimed invention by holding the claim unpatentable ... as indefinite.” Ex Parte Miyazaki, 89 USPQ2d 1207, 1211 (BPAI 2008) (precedential). Claim 1 requires, inter alia, “a highly crystalline polyolefin dispersion.” Appeal Br. 10 (Claims App.). The term “highly” is one of degree. Terms of degree are not inherently indefinite but must provide “enough certainty to one of skill in the art when read in the context of the 3 Appeal 2017-000891 Application 14/024,812 invention.” Interval Licensing LLC v. AOL, Inc., 766 F.3d 1364, 1370 (Fed. Cir. 2014). Here, Appellant argues that the phrase “highly crystalline polyolefin” is well known in the art and understood to mean having a crystalline content of 50% or greater. Appeal Br. 3^4. Appellant cites to a reference from Dow Chemical which provides that “conventional olefin fiber, such as drawn polypropylene fiber (Figure 1 b, page 5), is highly crystalline with degree of crystallinity greater than 50 percent.” Appeal Br. 3.2 Appellant additionally submits a journal article which refers to certain “highly crystalline (62—80%) materials.” G. Rojas et al., Precision polyolefin structure: Modeling polyethylene containing alkyl branches, 49 Polymer 2985—2995 (2008). Moreover, the Specification identifies three specific commercially available materials it describes as “highly crystalline pure polyolefin polymers.” Appeal Br. 5—6. The Examiner does not accept Appellant’s proffered evidence. The Examiner finds as follows: A search for “highly crystalline polyolefin” produces references teaching] that “greater than 35%” or “greater than 40%” meet “highly crystalline polyolefin.” Other reference patent [sic] disclose that a range of 80% or greater is required for a “highly crystalline polyolefin.” Still other references state that the requirement is 95% or more crystallinity. Answer 8. In the Reply, Appellant appears to abandon their prior position that “highly crystalline” is known to mean having a degree of crystallinity greater than 50 percent. Reply 2—6. Appellant further indicates agreement 2 Dow Chemical reference available at following url: www.ftc. gov/ sites/ default/files/documents/advisory_opinions/new-generic- fiber-petitiondow- chemical-company/petition_dowsubclass.pdf 4 Appeal 2017-000891 Application 14/024,812 with the Examiner’s finding that “‘[h]igh’ crystallinity can vary from polyolefin to polyolefin” and various polyolefins “may have entirely different properties and requirements for ‘high’ crystallinity.” Reply 2. Appellant further argues that “the present application does not provide the same specific value for ‘every type of polyolefin,’ but it does provide the same definition of ‘highly crystalline polyolefin’ via characterization and examples.” Id. at 4. Here, Appellant appears to argue that highly crystalline polyolefin polymer dispersions will have a sharp melting phase transition point rather than a gradual softening process. Id. In regard to polyolefin melting point, the Specification provides as follows: In an embodiment, the polyolefin polymer can be highly crystalline pure polyolefin polymer. In an embodiment, the polyolefin polymer can be characterized by exhibiting a particular type of differential scanning calorimetry (DSC) plot of the polyolefin endotherm. In such an embodiment, the observed endotherm can exhibit what is generally considered to be a sharp melting point. Spec. 5 (emphasis added). This falls short of defining “highly crystalline” in terms of sharpness of melting point in a DSC plot. Indefiniteness is a question of law. Indefiniteness, however, sometimes requires resolution of underlying questions of fact. Teva Pharm. USA, Inc. v. Sandoz, Inc., 135 S.Ct. 831, 838 (2015). Here, the underlying question of fact is whether or not the scope of “highly crystalline polyolefin” would be understood by those of skill in the art. Appellant first submits evidence and argument in support of the notion that “the generally accepted definition in the scientific literature of highly crystalline polyolefins are those polyolefin materials with [a] degree of crystallinity greater than 50%.” Appeal Br. 3. Appellant then changes 5 Appeal 2017-000891 Application 14/024,812 tack and assert that “[t]he instant application does not provide one specific value for ‘every type of polyolefin’ because there isn't a specific value for every type of polyolefin. . . . The present application defines highly crystalline polyolefin by its characteristics and by examples [ ] because one skilled in the art knows there are different values.” Reply 2. Appellant’s evidence and argument in support of their “crystallinity greater than 50%” argument is insufficient in view of its conflict with the Examiner’s factual findings and Appellant’s subsequent reversal. Appellant’s argument that the “application defines highly crystalline polyolefin by its characteristics” is poorly supported by the Specification and is in tension with Appellant’s earlier argument. Accordingly, Appellant has not shown reversible error in the Examiner’s determination that the pending claims are indefinite in view of their recitation of the term “highly crystalline polyolefin.” Rejections 2 and 3. The Examiner rejected claims 1, 2, 5, 7, and 10 as anticipated by Strandburg and claims 1,2, 5—7, 9-10, and 21 as anticipated by Wang. Final Act. 3. It is ordinarily improper to reject a claim over prior art when the meaning of a claim cannot be determined. As the predecessor to our reviewing court explained, “[a]ll words in a claim must be considered in judging the patentability of that claim against the prior art. If no reasonably definite meaning can be ascribed to certain terms in the claim, the subject matter does not become obvious—the claim becomes indefinite.” In re Wilson, 424 F.2d 1382, 1385 (CCPA 1970); see also In re Steele, 305 F.2d 859, 862—63 (CCPA 1962) (“As we have previously indicated, our analysis of the claims leaves us in a quandary as to what in fact is covered by them. 6 Appeal 2017-000891 Application 14/024,812 We think the examiner and the board were wrong in relying on what at best are speculative assumptions as to the meaning of the claims and basing a rejection under 35 U.S.C. § 103 thereon.”). Here, the anticipation rejections require evaluation of the “highly crystalline polyolefin” limitation. See Appeal Br. 6 (“Strandburg does not disclose, teach, or suggest the use of a highly crystalline polyolefin dispersion”), 7 (“Wang does not disclose, teach, or suggest the use of a highly crystalline polyolefin dispersion”) (emphasis added). Accordingly, because we cannot ascertain the scope of the claims we reverse pro forma the rejections of claims 1, 2, 5—7, 9, 10, and 21 on the basis of anticipation. The present reversal is predicated upon procedure rather than on the merits of the obviousness rejections. The reversal does not mean that we consider the claims to be patentable as drawn. CONCLUSION The rejections of claims 1, 2, 5—7, 9, 10, and 21 as indefinite is affirmed. We reverse the rejections of claims 1, 2, 5—7, 9, 10, and 21 on the basis of anticipation. No time period for taking any subsequent action in connection with this appeal may be extended under 37 C.F.R. § 1.136(a). AFFIRMED 7 Copy with citationCopy as parenthetical citation